Garth Lees-Rolfe insider trades
Open-market stock purchases and sales by Garth Lees-Rolfe, Chief Financial Officer at Inhibikase Therapeutics, Inc, from SEC Form 4 filings since Apr 1, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- IKT Inhibikase Therapeutics, Inc: other filings, last Jan 21, 2025